Pharmaceutical development is the process of identifying and assessing the procedures required to turn an active pharmaceutical component into a drug product that is appropriate for the use for which it is intended. This will be for small-scale production of a product to be utilised in clinical trials in the early phases of medication development. In order to be appropriate for production on a commercial scale, the method will have to be modified and enhanced if the tests are successful. Measuring the characteristics of the drug material and determining the essential qualities of the desired medication product are the first steps in the pharmaceutical development process. This procedure will involve determining the drug's stability and absorption characteristics as well as the best route of delivery (oral, parenteral or for local administration). It is crucial to match the qualities of the drug material with the formulation required to achieve the clinical and commercial profile. Drug substance characteristics may significantly restrict the types of formulations that may be employed and necessitate in-depth research to fulfil the necessary profile. In order to create a successful commercial product, pharmaceutical development of the drug substance, the drug product, and its manufacturing behaviour are required if the drug application is successful. The finished product needs to be secure, dependable, and efficient.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia